Aflibercept Dose in Polypoidal Choroidal Vasculopathy

JAMA Ophthalmology Author Interviews
18/12/2025 16 min
Aflibercept Dose in Polypoidal Choroidal Vasculopathy

Listen "Aflibercept Dose in Polypoidal Choroidal Vasculopathy"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy

More episodes of the podcast JAMA Ophthalmology Author Interviews

The Central Role of Home Hazards in Shaping the Association of Visual Function and Falls in Older Adults 11/12/2025
Foundation Models vs Physicians in Ophthalmological Questions 13/11/2025
Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy 30/10/2025
Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players 18/09/2025
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy 07/08/2025
Steroids and Cross-Linking for Ulcer Treatment 24/07/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 17/07/2025
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023 01/05/2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab 06/03/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA